Piergiulio Lauriano, MBA, is a strategist and innovator that combines a passion for business and finance with his hands on technology background. He spent his early career working for a management consulting firm in the US and Italy where he specialized in Healthcare Providers, Biotech, Medtech and Digital Health advising multinational and midsize companies on corporate strategy and restructuring, organic growth, portfolio innovation, and M&A.
At Alira Health he works between the Management Consulting and Investment Banking divisions where he advised a number of blue-chip companies often at the intersection of Medtech, Biotech and Digital Health domains focusing on portfolio innovation and prioritization, business planning, organic and inorganic growth. He has gained considerable market experience across different domains including Surgery comprising MIS and Robotics, Patient Monitoring, Oncology, Addiction, Diabetes, Orthopedics, Cell Therapies, Plasma derivatives, Infections Prevention and Control, Consumer Health, and Woundcare.
Prior to joining Alira Health, he was Director of Strategy and Innovation at Unifarm, a Healthcare conglomerate with almost $1B turnover, where he informed M&A and organic growth strategy initiatives.
Piergiulio pursued his MBA at IE Business School where he was selected for the MBA Advanced Management Program at Yale School of Management and scored in the top 10% of the class. In addition, he holds a M.Sc in Managerial Engineering with a Diplome de Grande Ecole from École Centrale de Nantes and a M.Sc in Robotics and Computer Engineering from the University of Genova.